Overview
Heike Weighardt practices practicing medicine in Bonn, Germany.
Her clinical expertise encompasses Hydrocele, Atopic Dermatitis, Oral Herpes, and Contact Dermatitis.
She is actively involved in clinical research, co-authoring 42 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Heike Weighardt
Is Heike Weighardt a top-rated expert for Hydrocele?
MediFind is an objective health platform that identifies experts based on real-world data. Heike Weighardt is classified as an Experienced expert for Hydrocele, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Heike Weighardt participate in research or clinical trials?
Yes. Heike Weighardt has published 42 articles and abstracts on conditions like Hydrocele. You can view a list of Heike Weighardt's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Atopic DermatitisMs. Weighardt isExperienced. Learn about Atopic Dermatitis.
- Contact DermatitisMs. Weighardt isExperienced. Learn about Contact Dermatitis.
- HydroceleMs. Weighardt isExperienced. Learn about Hydrocele.
- Oral HerpesMs. Weighardt isExperienced. Learn about Oral Herpes.